Last month, a second phase 3 blow for Marinus Pharmaceuticals prompted the Pennsylvania-based drugmaker to turn an eye toward ...

The last update, which, I believe, is another huge one, would be that the goal of this company is to expand the use of ...

NRBO READ THE FULL NRBO RESEARCH REPORT Business Update Topline Results from Phase 2a Trial of DA-1241 in MASH Expected in ...

EBR Systems is among ASX healthcare stocks with upcoming catalysts, expecting feedback on a FDA substantive review expected ...

The second phase of Courier Square by Greystar and Evening Post Industries includes a mixed-use retail and apartment ...

A modern, flexible office space at One Central, The Offices 2, Level 2, has been leased on a long-term basis to a single ...

Ulta Beauty's shift towards aggressive store expansion is expected to boost future growth. Read why I upgrade ULTA stock from ...

The initiation of this Phase 3 program follows the announcement in June 2024 of the successful outcome of MoonLake's ...

Announcing the partnership today, Corrib confirmed that as part of the first phase of the agreement, it plans to open ten ...

Humacyte, Inc. recently announced the presentation of results from the V007 phase 3 clinical trial of the company’s acel ...

Minbos Resources (ASX:MNB) has signed a subscription agreement with Angolan sovereign wealth fund Fundo Soberano de Angola ...

A slow launch for Alzheimer's medicine Leqembi, a lackluster pipeline and a challenging drug launch environment are just a ...